NCT06037720

Brief Summary

Intraoperative coagulopathies in complex procedures are common. For the diagnosis and adequate therapy, laboratory tests are necessary, which can delay the patient's therapy. In this sense, the study aims to evaluate the point-of-care test device for patients undergoing surgeries with cardiopulmonary bypass. Objective: To analyze the accuracy between the point-of-care diagnostic method and the laboratory test considered the gold standard for checking the INR. Methodology: Cross-sectional study of diagnostic accuracy with simultaneous testing of the Coaguchek XS device and standard laboratory method in patients undergoing cardiopulmonary bypass to evaluate INR results.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 14, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

4 months

First QC Date

September 7, 2023

Last Update Submit

September 7, 2023

Conditions

Keywords

CoaguChek® XS SystemInternational normalized ratioPoint-of-care testingCardiopulmonary bypass

Outcome Measures

Primary Outcomes (1)

  • Point-of-care diagnostic method

    To analyze the accuracy between the point-of-care diagnostic method and the laboratory test considered the gold standard for verifying the INR.

    During surgery

Interventions

Patients scheduled electively to undergo cardiac surgery with cardiopulmonary bypass at Hospital de Base in the Federal District.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled electively to undergo cardiac surgery with cardiopulmonary bypass at Hospital de Base in the Federal District.

You may qualify if:

  • patients over 18 years old
  • admitted to the Hospital de Base of the Federal District for cardiac surgery, who volunteered to participate in the examination both by the traditional method of venous INR examination and by the use of the Coaguchek device and only after signing the TCLE.

You may not qualify if:

  • patients who give up the research even after signing the TCLE will be excluded
  • patients who refuse to participate in the study
  • patients with kidney, liver, hematological disease or any disease that affects coagulation
  • patients participating in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Khalaf-Adeli E, Alavi M, Alizadeh-Ghavidel A, Pourfathollah AA. Comparison of standard coagulation testing with thromboelastometry tests in cardiac surgery. J Cardiovasc Thorac Res. 2019;11(4):300-304. doi: 10.15171/jcvtr.2019.48. Epub 2019 Oct 13.

    PMID: 31824611BACKGROUND
  • Mendonca FT, Matos SH, Moreira LG, Pereira IL, Dino LL, Braga MB, Dias GHDS. Accuracy of a point-of-care CoaguChek test versus standard laboratory coagulation monitoring in cardiac surgery involving cardiopulmonary bypass: randomized clinical trial. Braz J Anesthesiol. 2025 Nov 22;76(2):844714. doi: 10.1016/j.bjane.2025.844714. Online ahead of print.

Central Study Contacts

Nadja Gloria C Graça, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSc, PhD

Study Record Dates

First Submitted

September 7, 2023

First Posted

September 14, 2023

Study Start

September 1, 2023

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

September 14, 2023

Record last verified: 2023-09